Do patients suffering from heart failure (HF) and chronic obstructive pulmonary disease (COPD) tolerate beta blocker (BB) treatment?

T. Gil, C. Medina, L. Fernández, F. J. Martínez, A. Ramírez, J. R. Siles, F. Ruiz (Marbella, Estepona, Spain)

Source: Annual Congress 2011 - Comorbidities and management in primary care
Session: Comorbidities and management in primary care
Session type: Oral Presentation
Number: 2962
Disease area: Airway diseases

Congress or journal article abstractE-posterSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Gil, C. Medina, L. Fernández, F. J. Martínez, A. Ramírez, J. R. Siles, F. Ruiz (Marbella, Estepona, Spain). Do patients suffering from heart failure (HF) and chronic obstructive pulmonary disease (COPD) tolerate beta blocker (BB) treatment?. Eur Respir J 2011; 38: Suppl. 55, 2962

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006

The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Increased prevalence of obstructive airways disease (OAD) in patients with ischemic heart disease (IHD) and hypertension (HT)
Source: Eur Respir J 2007; 30: Suppl. 51, 122s
Year: 2007

Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016

Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF)
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016

Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

Does tolerance of neuro-muscular electrical stimulation (NMES) relate to gender in patients with an acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2012 - Physiotherapy and rehabilitative interventions applied to different populations with respiratory impairment
Year: 2012


The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007

Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 241s
Year: 2003

Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 564s
Year: 2002

The estimation of respiratory muscles (RM) status by echodensitometry in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012


Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Measurement of improved activities after pulmonary rehabilitation (PR) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 223s
Year: 2001

COPD and co-existent chronic heart failure (CHF): Response to pulmonary rehabilitation (PR)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016


Effects of a respiratory rehabilitation program over pulmonary hypertension (PH) and other right ventricular function measurements in a chronic obstructive pulmonary disease (COPD) population
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020


Physical activity after discharge following chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF) exacerbations
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015

Treating exacerbations of asthma or chronic obstructive pulmonary disease (COPD) with high frequency chest wall oscillation (HFCWO) in hospitalized patients
Source: Annual Congress 2010 - New or old physiological parameters in chronic airway disorders?
Year: 2010


Effects of Diltiazem on pulmonary hemodynamics and right heart function in patients with chronic obstructive pulmonary disease (COPD)>
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020